Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2025-12-24 @ 3:37 PM
NCT ID:
NCT06005792
Eligibility Criteria:
Inclusion Criteria:
The main inclusion and exclusion criteria include, but are not limited to, the following:
* Have active mild-to-severe plaque psoriasis or moderate-to-severe atopic dermatitis according to study-specific criteria
* Weight between 40 to 150 kg, inclusive
* No topical treatments for psoriasis or atopic dermatitis for 2 weeks before randomization
* No phototherapy for psoriasis for 4 weeks before randomization
* Washout of oral treatments for psoriasis or atopic dermatitis for 4 weeks before randomization
* Washout of biologic treatments for psoriasis or atopic dermatitis for 12 weeks before randomization
* Stated willingness to comply with all study procedures (including skin biopsies) and availability for the duration of the study
Exclusion Criteria:
* Patients with a history of active asthma within 5 years of screening, except those that have well controlled asthma symptoms at screening visit.
* Patients who have had any prior investigational treatment with IL-2 therapies
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT06005792
Study Brief:
Protocol Section:
NCT06005792